Advocacy Spotlight: Sorting Out Priorities Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions. by Cici Zhang Forward Look Little Consensus on Ovarian Cancer Monitoring Tests and scans may be overused. by Kate Yandell Survivor Profile Going Full Bore Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense. by Sue Rochman Forward Look Identifying Ovarian Cancer Risk Study may help spotlight women who would benefit from risk reduction strategies. by Carrie Printz Healthy Habits A Cup of Tea? Black tea consumption may be associated with a reduced risk of ovarian cancer. by Kurt Ullman First Person Never Alone: A Family Journey A mother and daughter exchange thoughts about their “full-family experience” facing an ovarian cancer diagnosis and treatment. by Mary (Dicey) Jackson Scroggins and Nneka Scroggins Survivor Profile Regaining Her Balance Gymnast Shannon Miller's focus and agility helped her capture seven Olympic medals before she was 20. But the most decorated U.S. gymnast in history struggled to overcome the shock of her ovarian cancer diagnosis and treatment. by Kevin Begos Yesterday & Today From Desire to Daisy Whether it was a star turn playing Blanche DuBois or Daisy Werthan, Jessica Tandy sparkled in a tough role. That didn't change after her cancer diagnosis. by Karen Patterson Q&A Writing Through It In a new book and on her New York Times blog, author Susan Gubar chronicles her experiences living with metastatic cancer. by Marci A. Landsmann Survivor Profile Patients’ Rights Powerhouse Myra Christopher wages a personal battle with a rare cancer while continuing to passionately advocate for patients. by Charlotte Huff Cancer Talk Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor What Do Clinical Trial Endpoints Really Measure? A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life. by Jon Kelvey Shingles Risk Increased for Cancer Patients A new vaccine is safe for cancer patients but hard to find. by Nancy Averett More Posts